scholarly journals Reply to: “C-reactive protein levels in non-alcoholic fatty liver disease”

2012 ◽  
Vol 56 (2) ◽  
pp. 508-510
Author(s):  
Tine Jess ◽  
Esther Zimmermann ◽  
Rodolphe Anty ◽  
Joan Tordjman ◽  
An Verrijken ◽  
...  
Keyword(s):  
Liver Disease ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
C Reactive Protein ◽  
Alcoholic Fatty Liver ◽  
Protein Levels ◽  
Reactive Protein ◽  
Alcoholic Fatty Liver Disease

scholarly journals C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients

2011 ◽  
Vol 55 (3) ◽  
pp. 660-665 ◽  
Author(s):  
Esther Zimmermann ◽  
Rodolphe Anty ◽  
Joan Tordjman ◽  
An Verrijken ◽  
Philippe Gual ◽  
...  
Keyword(s):  
Liver Disease ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Obese Patients ◽  
C Reactive Protein ◽  
Alcoholic Fatty Liver ◽  
Protein Levels ◽  
Reactive Protein ◽  
Alcoholic Fatty Liver Disease

scholarly journals Changes of carbohydrate and lipid metafbolism and c-reactive protein in patients with ischemic heart disease and fatty hepatose

2017 ◽  
Author(s):  
S. А. Tkachuk ◽  
H. V. Bashta ◽  
L. Ye. Lapovets ◽  
M. P. Zaletskyi
Keyword(s):  
Heart Disease ◽  
Liver Disease ◽  
Ischemic Heart Disease ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Ischemic Heart ◽  
C Reactive Protein ◽  
Alcoholic Fatty Liver ◽  
Reactive Protein ◽  
Alcoholic Fatty Liver Disease

The aim of the study was to detect changes in lipid and carbohydrate metabolism and the level of C-reactive protein in patients with ischemic heart disease, combined with non-alcoholic fatty liver disease. Widespread ischemic heart disease combined with non-alcoholic fatty liver disease requires finding mutual pathogenetic mechanisms for improving the diagnosis and treatment optimization to improve the course and prognosis of these comorbid diseases. Patients with non-alcoholic fatty liver disease must be classified as high-risk population.

Sign in / Sign up

Export Citation Format

Share Document